Prelude Capital Management’s Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 BURU.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,359
Closed -$1K 1730
2022
Q3
$1K Hold
14,359
﹤0.01% 1498
2022
Q2
$1K Hold
14,359
﹤0.01% 1767
2022
Q1
$2K Hold
14,359
﹤0.01% 1735
2021
Q4
$7K Buy
+14,359
New +$8.54K ﹤0.01% 1937

Other funds holding BURU.WS

Prelude Capital Management's BURU.WS Position: Q4 2022 in Review

Prelude Capital Management sold out of Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (BURU.WS) in Q4 2022, closing a stake of 14,359 shares — an estimated $1K sold.

Prelude Capital Management first reported a position in BURU.WS in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 39 funds tracked by Wall St. Rank hold BURU.WS as of Q4 2022.

  • Prelude Capital Management reported no remaining Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 14,359 Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $1K.
  • Prelude Capital Management first reported a position in Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 4 quarters.
  • Prelude Capital Management's Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $7K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.